Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders-Reference-Cited by-同舟云学术

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders

Published:2006-07-24 Issue:3 Volume:9 Page:293-348
ISSN:1875-8908
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Abdi Fadi¹,Quinn Joseph F.²,Jankovic Joseph³,McIntosh Martin⁴,Leverenz James B.⁵,Peskind Elaine⁵,Nixon Randy²,Nutt John²,Chung Katherine²,Zabetian Cyrus⁵,Samii Ali⁵,Lin Melanie¹,Hattan Stephen¹,Pan Catherine⁵,Wang Yan⁵,Jin Jinghua⁵,Zhu David⁵,Li G. Jane⁵,Liu Yan⁴,Waichunas Dana²,Montine Thomas J.⁵,Zhang Jing⁵

Affiliation:

1. Applied Biosystems, Framingham, MA, USA

2. Oregon Health and Science University, Portland, OR, USA

3. Baylor College of Medicine, Houston, TX, USA

4. Fred Hutchison Cancer Research Center, Seattle, WA, USA

5. University of Washington School of Medicine, Seattle, WA, USA

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 295 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sampling methods and biomarkers for early detection of neurodegenerative disorders;Smart Diagnostics for Neurodegenerative Disorders;2024

2. Elucidating distinct molecular signatures of Lewy body dementias;Neurobiology of Disease;2023-11

3. CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease;Nature Communications;2023-09-13

4. Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis;Clinical Proteomics;2023-08-29

5. Aggregation and beyond: alpha-synuclein-based biomarkers in synucleinopathies;Brain;2023-08-01